284 studies found for: Open Studies | "Carcinoma, Renal Cell"
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)
Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
PII SBRT + Microwave Ablation in Renal Cell Carcinoma
Intraoperative Dual-modality Imaging in Renal Cell Carcinoma
Glycosaminoglycan Scores as Predictive Biomarkers in Confined Renal Cell Carcinoma
Glycosaminoglycan Scores as Predictive Biomarkers in Advanced Renal Cell Carcinoma
Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
|9||Not yet recruiting||
Pazopanib Vs. Local Therapy for Renal Cancer With Metastases
A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Stereotactic Radiotherapy for Renal Cancers
|15||Not yet recruiting||
A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma
Kidney Cancer DNA Registry
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
† Study has passed its completion date and status has not been verified in more than two years.